What is the current Zai Lab market capitalization?
The current market capitalization of Zai Lab is 2.24 B USD.
Zai Lab Market capitalization 2024
Zai Lab Market capitalization
2.24 B USD
Ticker
9688.HK
ISIN
KYG9887T1085
WKN
A2DX7H
In 2024, Zai Lab's market cap stood at 2.24 B USD, a -5.76% increase from the 2.38 B USD market cap in the previous year.
The Zai Lab Market capitalization history
| YEAR | Market Capitalization (undefined USD) |
|---|---|
| 2023 | 3.01 |
| 2022 | 3.78 |
| 2021 | 12.53 |
| 2020 | 7.7 |
| 2019 | - |
| 2018 | - |
| 2017 | - |
| 2016 | - |
Zai Lab Aktienanalyse
What does Zai Lab do?
Zai Lab Ltd is a biotech company based in Shanghai, China, that focuses on the development and commercialization of innovative drugs and therapies for unmet medical needs. The company's history dates back to 2014 when Dr. Samantha Du, an experienced pharma executive, founded the company to realize her vision of a modern, science-based biotech company in China. Zai Lab's business model is based on several strategic pillars. On one hand, the company collaborates with leading pharma and biotech research centers to discover, develop, and market new active ingredients and therapies. On the other hand, Zai Lab also promotes the acquisition of promising companies and technologies to strengthen its innovative power and expand its product portfolio. Another important aspect of Zai Lab's business model is its close collaboration with the Chinese government and healthcare system to simplify and improve access to new drugs and therapies for patients in China. Zai Lab operates in various business areas and markets to cover a wide range of medical needs. One of Zai Lab's main areas is oncology pharmaceuticals used to treat cancer. The company has focused primarily on novel active ingredients that have the potential to selectively target certain types of cancer cells while sparing healthy cells. Zai Lab's key oncology products include Niraparib, a PARP inhibitor for the treatment of ovarian cancer, and ZL-2301, a SHRPI inhibitor for the treatment of liver and lung cancer. Another important business area for Zai Lab is immunology and autoimmunity. Here, the company develops new therapies and medications that can modulate and regulate the immune system in certain disease conditions. One of the most promising products is the drug FOLFIRINOX, an immunomodulator for the treatment of chronic inflammatory bowel diseases. In addition to oncology and immunology, Zai Lab is also involved in other areas of medicine such as gastroenterology, infectious diseases, and neuroscience. In these fields, the company develops new antibiotics, vaccines, and medications for the treatment of diseases such as hepatitis B, Lyme disease, and Alzheimer's. Overall, Zai Lab aims to improve the health and well-being of patients in China and worldwide through its broad product range and innovation power. In recent years, Zai Lab has written an impressive growth story. The company has raised several million dollars in investments since its inception and has built a strong network and collaboration with other companies. Recently, Zai Lab has also attracted additional investors through IPOs in Hong Kong and New York, further strengthening its position as a leading biotech company in China. Overall, Zai Lab is an emerging biotech company that aims to fulfill medical needs in China and worldwide with its broad range of products and services and its innovation power. The company relies on close collaboration with leading research centers, companies, and government agencies, and strives to improve the health and well-being of patients worldwide. Zai Lab ist eines der beliebtesten Unternehmen auf Eulerpool.com.Market capitalization Details
Exploring Zai Lab's Market Capitalization
Zai Lab's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.
Year-to-Year Comparison
A yearly comparison of Zai Lab's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.
Impact on Investments
Zai Lab's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.
Interpreting Market Capitalization Fluctuations
Variations in Zai Lab’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.
Frequently Asked Questions about Zai Lab stock
What is market capitalization?
The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Zai Lab.
How has the market capitalization of Zai Lab developed in recent years?
The market capitalization of Zai Lab has increased/decreased by -5.76% compared to the previous year.
What does market capitalization mean for investors?
The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.
Why is market capitalization an important indicator for investors?
The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.
Why does the market capitalization fluctuate?
The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.
What role does market capitalization play in the valuation of Zai Lab?
In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.
Does the market capitalization influence the performance of Zai Lab?
There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
Does the market capitalization of Zai Lab have an influence on indices?
Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).
How much dividend does Zai Lab pay?
Over the past 12 months, Zai Lab paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Zai Lab is expected to pay a dividend of 0 USD.
What is the dividend yield of Zai Lab?
The current dividend yield of Zai Lab is .
When does Zai Lab pay dividends?
Zai Lab pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Zai Lab?
Zai Lab paid dividends every year for the past 0 years.
What is the dividend of Zai Lab?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Zai Lab located?
Zai Lab is assigned to the 'Health' sector.
Wann musste ich die Aktien von Zai Lab kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Zai Lab from 9/30/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/30/2024.
When did Zai Lab pay the last dividend?
The last dividend was paid out on 9/30/2024.
What was the dividend of Zai Lab in the year 2023?
In the year 2023, Zai Lab distributed 0 USD as dividends.
In which currency does Zai Lab pay out the dividend?
The dividends of Zai Lab are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Zai Lab
Our stock analysis for Zai Lab Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Zai Lab Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
